-

The Federal Court of Canada Certified a Class Action Lawsuit Against Her Majesty the Queen (“Health Canada”) Concerning the Mailing of Approximately 40,000 Letters to Participants in the Marihuana Medical Access Program in November 2013

TORONTO--(BUSINESS WIRE)--The Federal Court of Canada has authorized a class action against Her Majesty the Queen on behalf of the following Group:

All persons who were sent a letter from Health Canada in November 2013 that had the phrase Marihuana Medical Access Program on the envelope.

The action alleges, among other things, that Health Canada breached the privacy of members of the Marihuana Medical Access Program when it sent the approximately 40,000 letters to participants in the Marihuana Medical Access Program in November 2013, in envelopes referring explicitly to the “Marihuana Medical Access Program” or “Programme d'accès à la marihuana a des fins médicales”.

The plaintiffs are asking the Court to order Health Canada to pay compensation to affected individuals for, among other things, the alleged breach of privacy. Health Canada denies that it did anything wrong.

If you wish to participate in the class action, DO NOTHING.

If you do not wish to participate in the class action, you must opt out by sending an opt-out request to Trilogy Class Action Services by July 21, 2022. If you opt out, the results of the lawsuit will not apply to you and you will not be entitled to receive any money through the lawsuit.

The notice of certification, opt-out procedure, and other important information about the class action is available here: www.medicalmarihuanaprivacyclassactioncanada.ca.

Contacts

Paul Battaglia
President, Trilogy Class Action Services,
1-877-406-5302
Inquiry@trilogyclassactions.ca

Twitter: @ClassMarihuana

Industry:

Trilogy Class Action Services

Release Versions
EnglishFrench

Contacts

Paul Battaglia
President, Trilogy Class Action Services,
1-877-406-5302
Inquiry@trilogyclassactions.ca

Twitter: @ClassMarihuana

More News From Trilogy Class Action Services

Berger Montague (Canada) PC Announces Shareholder Investigation Into Standard Lithium Ltd.

TORONTO--(BUSINESS WIRE)--Berger Montague (Canada) P.C. is announcing that it has been directed by its clients to investigate Standard Lithium Ltd. (“Standard Lithium) (TSX: “SLI” and FRA: “S5L”) concerning its Third Quarter 2023 Results. Standard Lithium held itself out as focused on commercializing its “proprietary” direct lithium extraction process, which the company claimed could achieve the remarkable recovery rate of about 90% of lithium extracted from brine. On November 18, 2021, Blue Or...

Berger Montague (Canada), P.C. Announces Re-investigation Into Previously Published Reports Regarding Reconnaissance Energy Africa, Ltd. Target Price Cut by Over 40% Triggers Investors' Second Investigation

TORONTO--(BUSINESS WIRE)--Berger Montague (Canada) P.C. announces that it has been invited to re-investigate previously published reports about Reconnaissance Energy Africa Ltd. (“ReconAfrica” or the “Company”) (TSXV: RECO; OTCQX: RECAF; and FRA: 0XD). On April 23, 2023, a U.S. federal court denied ReconAfrica's motion to dismiss the U.S. shareholder class action claims and was ordered to file an answer to the complaint that it previously misled investors. After the Company's November 2022, inv...

Siskinds LLP, Merchant Law Group LLP and Siskinds Desmeules, Avocats Announce the Settlement of Invokana®, Invokamet® and/or Invokamet XR®Class Action Litigation

LONDON, Ontario & REGINA, Saskatchewan & QUEBEC CITY--(BUSINESS WIRE)--James Boyd of Siskinds LLP, E.F. Anthony Merchant K.C. of Merchant Law Group, and Chloé Faucher-Lafrance of Siskinds Desmeules, Avocats announce that a Canada-wide settlement has been reached in three class actions relating to the prescription drugs Invokana®, Invokamet®, and Invokamet XR®. The Settlement of the Proceedings has been approved by the Courts. The Defendants deny all allegations and deny any wrongdoing or liabil...
Back to Newsroom